Tigecycline description: Difference between revisions
(Created page with "__NOTOC__ {{Tigecycline}} {{CMG}}; {{AE}} {{SS}} ==Description== TYGACIL (tigecycline) is a tetracycline derivative (a glycylcycline) for intravenous infusion. The chemical n...") |
No edit summary |
||
| Line 24: | Line 24: | ||
{{FDA}} | {{FDA}} | ||
[[Category: | [[Category:Glycylcycline]] | ||
[[Category:Wikinfect]]}} | [[Category:Wikinfect]]}} | ||
Latest revision as of 04:31, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Description
TYGACIL (tigecycline) is a tetracycline derivative (a glycylcycline) for intravenous infusion. The chemical name of tigecycline is (4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide. The empirical formula is C29H39N5O8 and the molecular weight is 585.65.
The following represents the chemical structure of tigecycline:
TYGACIL is an orange lyophilized powder or cake. Each TYGACIL vial contains 50 mg tigecycline lyophilized powder for reconstitution for intravenous infusion and 100 mg of lactose monohydrate. The pH is adjusted with hydrochloric acid, and if necessary sodium hydroxide. The product does not contain preservatives.[1]
References
Adapted from the FDA Package Insert.}}